| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18784101 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 131 journal articles in the PubMed database | Email to a friend | | |
| Vermorken JB, Mesia R, Rivera F, et al.
Platinum-based chemotherapy plus cetuximab in head and neck cancer. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
N Engl J Med 2008 Sep 11; 359(11):1116-27.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Baselga J, Trigo JM, Bourhis J, et al.
Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study]
J Clin Oncol 2005 Aug 20; 23(24):5568-77.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bourhis J, Rivera F, Mesia R, et al.
Phase I/II Study of Cetuximab in Combination With Cisplatin or Carboplatin and Fluorouracil in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck. [Journal Article]
J Clin Oncol 2006 Jun 20; 24(18):2866-72.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bonner JA, Harari PM, Giralt J, et al.
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2006 Feb 9; 354(6):567-78.
Abstract | Full Citation | Find Related Articles | | Herbst RS, Arquette M, Shin DM, et al.
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck. [Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study]
J Clin Oncol 2005 Aug 20; 23(24):5578-87.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Vermorken JB, Remenar E, van Herpen C, et al.
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. [Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
N Engl J Med 2007 Oct 25; 357(17):1695-704.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Worden FP, Moon J, Samlowski W, et al.
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: southwest Oncology Group study 0007. [JOURNAL ARTICLE]
Cancer 2006 Jun 15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Burtness B, Goldwasser MA, Flood W, et al.
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Clin Oncol 2005 Dec 1; 23(34):8646-54.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Vermorken JB, Herbst RS, Leon X, et al.
Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies. [Journal Article]
Cancer 2008 Jun 15; 112(12):2710-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
